Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis

NCT01000714 is registered in ClinicalTrials.gov with Etwal Ltd. as lead sponsor.

NCT NCT01000714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01000714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis
Lead sponsor
Etwal Ltd.
Phase
Phase 2
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild to moderate psoriasis